Feb. 22, 2024 When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

People taking phentermine can lose over 7% of their body weight, or at least 8 pounds.

Pharmacies currently making copycat versions of Eli Lilly’s tirzepatide face heightened exposure to state enforcement actions ...

The controlling shareholder in Novo Nordisk put in a request for EU approval for the deal on Oct. 31. The EU antitrust ...

Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalizations of people who had taken ...

Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...

Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO) on Tuesday asked the U.S. Food and Drug Administration to ban compounding ...

In today’s fast-paced world, weight management has become a significant concern for many individuals. With countless ...